| 000 | 01738 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513193013.0 | ||
| 264 | 0 | _c19991021 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0215(19991022)84:5<458::aid-ijc2>3.0.co;2-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdwards, S M | |
| 245 | 0 | 0 |
_aAndrogen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cOct 1999 |
||
| 300 |
_a458-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xetiology |
| 650 | 0 | 4 |
_aReceptors, Androgen _xgenetics |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTrinucleotide Repeats |
| 700 | 1 | _aBadzioch, M D | |
| 700 | 1 | _aMinter, R | |
| 700 | 1 | _aHamoudi, R | |
| 700 | 1 | _aCollins, N | |
| 700 | 1 | _aArdern-Jones, A | |
| 700 | 1 | _aDowe, A | |
| 700 | 1 | _aOsborne, S | |
| 700 | 1 | _aKelly, J | |
| 700 | 1 | _aShearer, R | |
| 700 | 1 | _aEaston, D F | |
| 700 | 1 | _aSaunders, G F | |
| 700 | 1 | _aDearnaley, D P | |
| 700 | 1 | _aEeles, R A | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 84 _gno. 5 _gp. 458-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0215(19991022)84:5<458::aid-ijc2>3.0.co;2-y _zAvailable from publisher's website |
| 999 |
_c10459870 _d10459870 |
||